The FSHD Society’s annual FSHD International Research Congress is the premier global conference exclusively focused on facioscapulohumeral muscular dystrophy (FSHD) research.
With the recent advances in FSHD research and clinical advances, this conference has become catalytic in translating ideas into potential therapies.
We invite clinicians, medical researchers, pharmaceutical industry leaders and basic scientists at all stages of their careers to present and discuss new developments, reinforce collaborative efforts, facilitate new initiatives, and coordinate research and clinical activities.
The meeting runs for two full days and includes keynotes, plenaries, poster sessions and social events. A highlight is the joint reception for the IRC-FSHD Connect patient conference, held after the second day of the conference. Expected attendance: 250 in person and 250 on-line.
Published on 1 October 0025.
